Edwards Lifesciences Corporation (EW) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | 43.8M | 450.9M | 573.7M | 290.2M | 280.4M | -127.5M | 351.8M | 371.5M | -53.5M | 136.6M | 411.5M | 33.6M |
| Operating CF Margin % | 2.66% | 28.73% | 36.94% | 18.94% | 19.85% | -9.2% | 25.97% | 26.81% | -4.02% | 10.79% | 33.09% | 2.59% |
| Operating CF Growth % | -84.38% | 453.65% | 63.08% | -21.88% | 624.11% | -193.34% | -14.51% | 1005.65% | -117.03% | -51.7% | 32.78% | -89.89% |
| Net Income | 380.7M | 91.2M | 290.3M | 331.5M | 356.4M | 385.6M | 3.07B | 365M | 351M | 369.7M | 383.7M | 305.5M |
| Depreciation & Amortization | 40.9M | 42.7M | 39.2M | 38.1M | 36.6M | 42.6M | 34.5M | 39.6M | 38.5M | 36.7M | 36.9M | 36.1M |
| Stock-Based Compensation | 45.4M | 39.2M | 41.2M | 37.5M | 40.2M | 50.8M | 42.1M | 43.9M | 44.6M | 30.5M | 32.6M | 37.4M |
| Deferred Taxes | 9.4M | -54.4M | -18M | -20.9M | -24.3M | -98.5M | -123M | -66.1M | -35.8M | -91.4M | -46M | -82.9M |
| Other Non-Cash Items | 68.9M | 77.9M | 137.5M | 45.7M | 22M | -44.9M | -3.35B | 9.9M | 7.2M | 7.2M | 16.5M | -21.1M |
| Working Capital Changes | -501.5M | 254.3M | 83.5M | -141.7M | -150.7M | -463.1M | 683.6M | -20.8M | -459M | -216.1M | -12.2M | -241.4M |
| Change in Receivables | -117.9M | 32.4M | 13.2M | -24.9M | -43.7M | 105.9M | 47.3M | 23M | -55M | -41.3M | -28.4M | -224.2M |
| Change in Inventory | -1.6M | 11M | -1.8M | 41.6M | -100K | -51.2M | -41.2M | -94.2M | -69.5M | -99.3M | -76M | -80.9M |
| Change in Payables | -347.1M | 168.7M | 226.1M | 103.7M | -103.4M | -3.1M | 29.9M | 151.8M | -89.1M | 33.4M | 36.4M | 121.4M |
| Cash from Investing | -92.8M | -198.3M | -427.8M | -172.1M | 85.3M | -576.7M | 2.7B | 124.8M | 63.1M | 14.1M | 89M | 70.2M |
| Capital Expenditures | -64.9M | -97.4M | -57.5M | -49.3M | -56M | -54.4M | -31.9M | -85.4M | -85.3M | -101.6M | -55.3M | -47.9M |
| CapEx % of Revenue | 3.94% | 6.21% | 3.7% | 3.22% | 3.96% | 3.93% | 2.36% | 6.16% | 6.41% | 8.02% | 4.45% | 3.7% |
| Acquisitions | -35.1M | -3M | 0 | 3M | -3M | -298.2M | 3.16B | 0 | 0 | 46M | 55.3M | 47.9M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -61.8M | -57.6M | -9.2M | -89.6M | -54M | -101.5M | -77.7M | -23.5M | -4.8M | -9.1M | -81.8M | -57.3M |
| Cash from Financing | -451.2M | -11.4M | -740.1M | 52.7M | -258M | 28.6M | -976.7M | -96.6M | 61.7M | -413.2M | -143.3M | 52.1M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | -452.9M | -8.3M | 157M | 51.7M | -208.7M | 28.5M | -901M | -158.1M | -200K | -448.4M | -174.4M | -7.5M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -521.8M | -40.6M | 157M | -5.5M | -258.6M | -100K | -901M | -158.1M | -200K | -448.4M | -174.4M | -7.5M |
| Other Financing | 1.7M | -3.1M | -897.1M | 1M | -50M | 100K | -75.7M | 61.5M | 61.9M | 35.2M | 31.1M | 59.6M |
| Net Change in Cash | -492M | 244.7M | -595.2M | 141.2M | 90M | -624.6M | 2.04B | 429.1M | 81M | -265.9M | 366.4M | 171.1M |
| Free Cash Flow | -21.1M | 353.5M | 516.2M | 240.9M | 224.4M | -177.3M | 319.9M | 286.1M | -138.8M | 35M | 356.2M | -14.3M |
| FCF Margin % | -1.28% | 22.52% | 33.24% | 15.72% | 15.88% | -12.79% | 23.62% | 20.64% | -10.44% | 2.76% | 28.65% | -1.1% |
| FCF Growth % | -109.4% | 299.38% | 61.36% | -15.8% | 261.67% | -606.57% | -10.19% | 2100.7% | -154.95% | -81.93% | 42.48% | -104.95% |
| FCF per Share | -0.04 | 0.61 | 0.88 | 0.41 | 0.38 | -0.30 | 0.53 | 0.47 | -0.23 | 0.06 | 0.58 | -0.02 |
| FCF Conversion (FCF/Net Income) | 0.12x | 4.94x | 1.97x | 0.88x | 0.78x | -0.33x | 0.11x | 1.02x | -0.15x | 0.37x | 1.07x | 0.11x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 19.6M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 340.6M | 51.2M | -633.8M | 104.9M | 179.7M | 349.2M | 0 | 25.6M | 171.8M |